文献速递心胸血管麻醉

Minto模型在体外循环期间瑞芬太尼靶控输注的性能评估

Performance of the Minto model for the target-controlled infusion of remifentanil during cardiopulmonary bypass.
PubMed 文献 · Anaesthesia · 2017-01-01

研究评估了Minto药代动力学模型在心脏手术体外循环期间瑞芬太尼靶控输注的预测性能。56例患者共采集275份动脉血样,汇总数据中位数预测误差为21.3%,体外循环期间为22.1%;深低温停循环期间预测误差达148.4%,实测浓度超过预测值三倍以上。Minto模型在体外循环期间存在明显偏差但总体精确度可接受,深低温停循环期间应降低瑞芬太尼目标浓度。

要点

  • Minto模型在体外循环期间存在明显偏差但总体精确度可接受
  • 深低温停循环期间预测误差达148.4%,实测浓度远超预测值
  • 深低温停循环期间使用Minto模型应降低瑞芬太尼目标浓度

核心结论

  • Minto模型在体外循环期间显示明显偏差但总体精确度可接受。
  • 深低温停循环期间使用Minto模型时应降低瑞芬太尼目标浓度。

研究设计与样本

  • 研究纳入56例接受心脏手术并采用丙泊酚全静脉麻醉的患者,使用Minto模型进行瑞芬太尼靶控输注。
  • 在体外循环前、中、后共采集275份动脉血样测定瑞芬太尼血浆浓度,并记录各时间点的预测浓度。

主要发现

  • 汇总数据的中位数预测误差为21.3%,中位数绝对预测误差为21.8%。
  • 体外循环期间中位数预测误差为22.1%,中位数绝对预测误差为22.3%。
  • 深低温停循环期间中位数预测误差和中位数绝对预测误差均为148.4%。
  • 深低温停循环期间实测浓度超过预测值三倍以上(26.9 (17.0) vs. 7.1 (1.6) ng.ml-1)。

临床怎么用

  • 体外循环期间使用Minto模型靶控输注瑞芬太尼时需注意模型偏差。
  • 深低温停循环期间应降低瑞芬太尼目标浓度以避免实测浓度过高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We studied the predictive performance of the Minto pharmacokinetic model during cardiopulmonary bypass in patients undergoing cardiac surgery. Patients received remifentanil target-controlled infusion using the Minto model during total intravenous anaesthesia with propofol. From 56 patients, 275 arterial blood samples were drawn before, during and after bypass to determine the plasma concentration of remifentanil, and the predicted concentrations were recorded at each time. For pooled data, the median prediction error and median absolute prediction error were 21.3% and 21.8%, respectively, and 22.1% and 22.3% during bypass. Both were 148.4% during hypothermic circulatory arrest and measured concentrations were more than three times greater than predicted (26.9 (17.0) vs. 7.1 (1.6) ng.ml-1 ). The Minto model showed considerable bias but overall acceptable precision during bypass. The target concentration of remifentanil should be reduced when using the Minto model during hypothermic circulatory arrest.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Cho YJ, Jo WY, Oh H, et al. Performance of the Minto model for the target-controlled infusion of remifentanil during cardiopulmonary bypass. Anaesthesia. 2017. PMID: 28891056. doi:10.1111/anae.14019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。